• Medical_Professionals
• Medical_students
• Nurses

With so many new and promising strategies and recent developments, the opportunities to produce and enable high-impact cancer research are unprecedented. Recent advances continue to expand and reshape our views of the essential features of cancer. We are learning important new aspects of how cancers develop, how to find and diagnose cancers earlier, how to design and unleash powerful new anti-cancer therapies, and how to evaluate cancer risk and even prevent tumors from arising. These advances are delivering useful, productive changes that lead to better cancer outcomes. 

In this special program, world leaders in cancer research share their insights and teach this changing science. Participants learn the new fundamentals of a wide spectrum of cancer science and the skills necessary to envision, design and lead cutting-edge cancer research projects that can contribute to these changes. 

This program is designed to help participants make high-impact contributions that lead to better cancer outcomes. As a participant, you will:

Explore the most current understanding of the molecular and cellular basis of cancer development, detection, diagnosis, treatment and prevention

Learn innovative science from the innovators themselves

Hear about new cancer treatments from the individuals who developed the therapies and are testing them in ongoing clinical trials

Hone the skills necessary to identify and answer key questions needed to make your own future contributions

Customize your learning experience for your specific interests

Build an international network of colleagues and friends

This Harvard Medical School program is open to both new and seasoned researchers. The customized facets of this program enable you to tailor your learning experience to your specific research interests and career goals. 

Julian Adams, PhD

Chairman

Gamida Cell

Chief Scientific Officer, President

Clal Biotechnology Industries

Joseph H. Antin, MD

Chief and Program Director, Stem Cell Transplantation

Dana-Farber Cancer Institute

Professor of Medicine

Harvard Medical School

Steve Arkinstall, PhD

Chief Scientific Officer

Kymab

Jon C. Aster, MD, PhD

Professor of Pathology

Harvard Medical School

Associate Pathologist

Brigham and Women's Hospital

Andrew H. Beck, MD, PhD

Assistant Professor of Pathology

Harvard Medical School

Director, Molecular Epidemiology Research Laboratory, Pathology

Beth Israel Deaconess Medical Center

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Harvard Medical School

25 Shattuck St.,

Boston,

Massachusetts,

United States

Submission Info

Office for External Education

4 Blackfan Circle

4th Floor

Boston, MA 02115

Office for External Education

4 Blackfan Circle

4th Floor

Boston, MA 02115